menu search

Novartis begins new era with profit beat and guidance hike

The Swiss pharmaceutical company says its transition to a pure-play innovative medicines business is no...

October 24, 2023, 5:44 am

Ardelyx shares positive data on symptom response during treatment with ibsrela® (tenapanor) for ibs-c and hosts ibs-c product theater at acg 2023

WALTHAM, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, devel...

October 23, 2023, 12:07 pm

Why revolution medicines stock is crashing today

Revolution medicines reported data from a phase 1 study of RMC-6236 in treating lung cancer and pancrea...

October 23, 2023, 12:04 pm

Catalyst pharmaceuticals to report third quarter 2023 financial results on november 8, 2023

The Company to Host a Conference Call and Webcast on November 9, 2023, at 8:30 AM ET CORAL GABLES, Fla., Oct. 23, 2023 (GLOBE NEWSWIRE) — Catalyst P...

October 23, 2023, 12:03 pm

Cvs to pull cold medicines deemed ineffective by fda

CVS Health (CVS) announced on Thursday that it will begin to pull several common cold products after an advisory panel from the FDA ruled that the act...

October 22, 2023, 8:00 am

Revolution medicines presents promising clinical activity and safety data from phase 1/1b trial of rmc-6236

Investor Webcast to be held Sunday, October 22 at 12:30 p.m. Eastern Time REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) — Revolution Medicine...

October 22, 2023, 6:30 am

Cvs health to remove cough medicines due to effectiveness doubts

CVS Health said yesterday it is to remove oral cough and cold products with phenylephrine as the only active ingredient from its shelves following gr...

October 20, 2023, 6:16 am

Cvs pulls popular cold medicines from store shelves

CVS said on Thursday that it is voluntarily removing certain common oral cough and cold products after a Food and Drug Administration (FDA) advisory p...

October 20, 2023, 4:15 am

Cvs to pull certain cold medicines containing decongestant phenylephrine from store shelves

The FDA has not decided whether to ask drug manufacturers and retailers like CVS to remove products containing oral phenylephrine from the market....

October 19, 2023, 4:02 pm

Ardelyx to report third quarter 2023 financial results on october 31, 2023

WALTHAM, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

October 18, 2023, 4:02 pm

Ardelyx announces amendment of debt financing agreement with slr capital partners to provide $50 million of additional committed capital

Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tena...

October 17, 2023, 11:23 pm

Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...

October 17, 2023, 12:05 pm

Abbvie: why you should pay attention to this high-yielding dividend king (rating downgrade)

Dividend Kings are the most battle-tested dividend payers on Wall Street, with AbbVie being just one of four in the healthcare sector. The pharmaceuti...

October 17, 2023, 9:20 am

Intellia's (ntla) hae candidate gets ema's prime designation

The European medicines Agency bestows a Priority medicines ...

October 16, 2023, 2:17 pm

Comera life sciences presents sqore™ platform technology data at podd: partnerships in drug delivery conference

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generat...

October 16, 2023, 12:00 pm

Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...

October 16, 2023, 11:00 am

Gsk cancer immunotherapy receives backing from key ema committee

GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immunotherapy drug, Jemperli (dostarlimab), has been recommended for approval by a key committee at the E...

October 16, 2023, 4:02 am

Merck to present latest research from oncology portfolio at esmo 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...

October 16, 2023, 2:00 am

Precede biosciences announces first scientific data from its liquid biopsy platform to be presented as an oral presentation at esmo 2023

Data from more than 400 patients across 15 cancers demonstrate the significance of the Precede approach to informing therapeutic decision making and c...

October 15, 2023, 10:05 pm

Gene therapy, parkinson's disease, and food science: bayer u.s. discusses the latest technology

Most Americans know Bayer (BAYN.DE) for its over-the-counter medicines like Aleve and Claritin. But tha...

October 15, 2023, 9:00 am


Search within

Pages Search Results: